Home / Tulane researchers awarded Ladies Leukemia League grants
Zhen Lin, MD, PhD, (bottom row far right) and William C. Wimley, PhD (bottom row far left) – were each recently awarded $35,000 Ladies Leukemia League grants to help support their leukemia and lymphoma research projects.
Two Tulane Cancer Center researchers – Zhen Lin, MD, PhD, Associate Professor of Pathology and Technical Director of Molecular Pathology Laboratory at Tulane University School of Medicine; and William C. Wimley, PhD, George A. Adrouny Professor of Biochemistry and Molecular Biology at Tulane School of Medicine – were each recently awarded $35,000 Ladies Leukemia League (LLL) grants to help support their leukemia and lymphoma research projects.
Founded in 1969, LLL is a volunteer organization of 225 women dedicated to raising funds for leukemia and lymphoma research in Louisiana, Mississippi and Texas. Since their founding, they have raised over $4.5 million, which they have distributed as "seed" money to research scientists working in leukemia and lymphoma research or related fields.
The LLL issues a call for grant applications each fall and then utilizes a panel of medical advisors to evaluate proposals and make recommendations for funding. They cap awards at $35,000 per investigator in order to provide support for as many worthy projects as possible.
Tulane's current grant recipients were recognized and awarded with the first half of their grants at the organization's annual grant recipient luncheon, which took place in April. The balance of their awards will be distributed at the halfway point in the grant period, during the organization's annual Fête de Noël Luncheon.
This luncheon / fashion show is LLL’s major annual fundraiser and a premiere benefit of the holiday season in New Orleans. It is scheduled to take place on Tuesday, November 28, 2023, at the Hilton Riverside Hotel. For more information, please click here.
Read more about the Tulane research projects selected to receive LLL funding this year in the latest Inroads newsletter from Tulane Cancer Center.